These findings indicate that bFGF is prognostically relevant in pathological features of breast cancer, such as tumor stage, grading, nodal stage, and survival, and suggest that it is a novel parameter for worse prognosis in nodal-negative breast cancer patients [204]. Here, FGF2 is linked to breast cancer.